Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Feb 19;2(2):CD011433.
doi: 10.1002/14651858.CD011433.pub2.

Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment

Silja P Markkula  1 , Nelson Leung, Victoria B Allen, Dominic Furniss
Affiliations
Meta-Analysis

Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment

Silja P Markkula et al. Cochrane Database Syst Rev. .

Abstract

Background: Breast cancer is the most common type of cancer amongst women worldwide, and one distressing complication of breast cancer treatment is breast and upper-limb lymphoedema. There is uncertainty regarding the effectiveness of surgical interventions in both the prevention and management of lymphoedema affecting the arm after breast cancer treatment.

Objectives: 1. To assess and compare the efficacy of surgical interventions for the prevention of the development of lymphoedema (LE) in the arm after breast cancer treatment.2. To assess and compare the efficacy of surgical interventions for the treatment of established LE in the arm after breast cancer treatment.

Search methods: We searched the Cochrane Breast Cancer Group's Specialised Register, the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the WHO International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov for all prospectively registered and ongoing trials on 2 November 2017. Reference lists of included studies were also handsearched by three review authors for additional eligible trials.

Selection criteria: All randomised controlled trials (RCTs) comparing a surgical intervention for the prevention or treatment of lymphoedema of the arm after breast cancer treatment to either standard intervention, placebo intervention, or another surgical intervention were included. Patients of both sexes and all ages who have had treatment for their breast cancer were considered. No limits were applied to language or study location. Three authors independently determined the eligibility of each study.

Data collection and analysis: Three authors independently extracted data for each included study using a pre-designed data extraction pro forma and used Cochrane's 'risk of bias' tool for assessing risk of bias. Dichotomous variables were analysed using the Mantel-Haenszel method to estimate risk ratios (RRs). Differences in continuous variables were expressed as mean differences (MDs). GRADE was used to assess the certainty of the evidence provided by the included studies.

Main results: Two studies involving 95 participants examined surgical interventions for preventing breast cancer-related lymphoedema. Both studies evaluated the efficacy of the lymphaticovenular anastomosis technique as part of a preventative management protocol. Both studies were deemed to be at unclear risk of bias overall. Statistical variation between the studies was low, which increases the reliability of the evidence. However, the two studies were conducted in the same centre. Lymphaticovenular anastomosis appears to result in a reduction in the incidence of lymphoedema compared to nonoperative management with a risk ratio of 0.20 (95% CI 0.06 to 0.63, P = 0.006; 95 participants; low-certainty evidence). The RCTs did not evaluate any of the secondary outcomes.One study involving 36 participants evaluated the effectiveness of vascularised lymph node transfer for treating breast cancer-related lymphoedema. The trial was deemed to be at unclear risk of bias. For participants suffering from stage 2 lymphoedema, the evidence suggested reductions in limb volume (MD -39.00%, 95% CI -47.37% to -30.63%, very low-certainty evidence), pain scores (MD -4.16, 95% CI -5.17 to -3.15, very low-certainty evidence), heaviness sensation (MD -4.27, 95% CI -5.74 to -2.80, very low-certainty evidence), mean number of infections/year (MD -1.22, 95% CI -2.00 to -0.44, very low-certainty evidence), and an improvement in overall function scores (MD -3.77, 95% CI -4.89 to -2.65, very low-certainty evidence) for those who had undergone vascularised lymph node transfer compared to those who had undergone no treatment.

Authors' conclusions: There is low-certainty evidence that lymphaticovenular anastomosis is effective in preventing the development of lymphoedema after breast cancer treatment based on the findings from two studies. One study providing very low-certainty evidence found that vascularised lymph node transfer is an efficacious option in the treatment of established stage 2 lymphoedema related to breast cancer. Important secondary outcomes in this review were rarely reported in the included studies. More high-quality RCTs are required to further elucidate the effectiveness of surgical interventions in the prevention and treatment of lymphoedema after breast cancer treatment. At the time of this review, no ongoing trials on this topic were identified.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Forest plot of comparison: 1 Development of LE, outcome: 1.1 Development of LE.
4
4
Forest plot of comparison: 2 Reduction of LE, outcome: 2.1 Reduction of LE [%].
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011433

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Boccardo 2009 {published data only}
    1. Boccardo FM, Ansaldi F, Bellini C, Accogli S, Taddei G, Murdaca G, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology 2009;42(1):1‐9. - PubMed
Boccardo 2011 {published data only}
    1. Boccardo FM, Casabona F, Friedman D, Puglisi M, DeCian F, Ansaldi F, et al. Surgical prevention of arm lymphoedema after breast cancer treatment. Annals of Surgical Oncology 2011;18(9):2500‐5. - PubMed
Dionyssiou 2016 {published data only}
    1. Dionyssiou D, Demiri E, Tsimponis A, Sarafis A, Mpalaris V, Tatsidou G, et al. A randomized control study of treating secondary stage II breast cancer‐related lymphoedema with free lymph node transfer. Breast Cancer Research and Treatment 2016;156(1):73‐9. - PubMed

References to studies excluded from this review

Brorson & Svensson 1998 {published data only}
    1. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plastic and Reconstructive Surgery 1998;102(4):1058‐67. - PubMed
Brorson 1997 {published data only}
    1. Brorson H, Svensson H. Complete reduction of lymphoedema of the arm by liposuction after breast cancer. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 1997;31:137‐43. - PubMed
Brorson 1998 {published data only}
    1. Brorson H, Svensson H, Norrgren K, Thorsson O. Liposuction reduces arm lymphedema without significant altering the already impaired lymph transport. Lymphology 1998;31:156‐72. - PubMed
Brorson 2000 {published data only}
    1. Brorson H. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer. Acta Oncologica 2000;39(3):407‐20. - PubMed
Campisi 2006 {published data only}
    1. Campisi C, Davini D, Bellini C, Taddei G, Villa G, Fulcheri E, et al. Is there a role for microsurgery in the prevention of arm lymphedema secondary to breast cancer treatment?. Microsurgery 2006;26(1):70‐2. - PubMed
Campisi 2014 {published data only}
    1. Campisi CC, Campisi CA. Microsurgery for prevention and early treatment of lymphatic disorders after nodal dissection. Vascular Surgery 2014;e:198.
Ciudad 2017 {published data only}
    1. Ciudad P, Manrique OJ, Dat S, Sacak B, Chang WL, Kiranantawat K, et al. A head‐to‐head comparison among donor site morbidity after vascularized lymph node transfer: pearls and pitfalls of a 6‐year single center experience. Journal of Surgical Oncology 2017;115:37‐42. - PubMed
Hou 2008 {published data only}
    1. Hou C, Wu X, Jin X. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Japanese Journal of Clinical Oncology 2008;38(10):670‐4. - PubMed
Maldonado 2011 {published data only}
    1. Maldonado GE, Pérez CA, Covarrubias EE, Cabriales SA, Leyva LA, Pérez JC, et al. Autologous stem cells for the treatment of post‐mastectomy lymphedema: a pilot study. Cytotherapy 2011;13(10):1249‐55. - PubMed
Saaristo 2012 {published data only}
    1. Saaristo AM, Niemi TS, Viitanen TP, Tervala TV, Hartiala P, Suominen EA. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Annals of Surgery 2012;255:468‐73. - PubMed
Youssef 2010 {published data only}
    1. Youssef TF. Liposuction in the treatment of post mastectomy arm edema. European Journal of Surgical Oncology 2010;36:850‐1.

Additional references

Augustin 2005
    1. Augustin M, Bross F, Földi E, Vanscheidt W, Zschocke I. Development, validation and clinical use of the FLQA‐I, a disease‐specific quality of life questionnaire for patients with lymphedema. Vasa 2005;34(1):31‐5. - PubMed
Becker 2006
    1. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long‐term results following microsurgical lymph node transplantation. Annals of Surgery 2006;243(3):313‐5. - PMC - PubMed
Brennan 1996
    1. Brennan MG, DePompolo RW, Garden FH. Focused review: postmastectomy lymphedema. Archives of Physical Medicine and Rehabilitation 1996;77(3 Suppl):S74‐80. - PubMed
Brorson 2002
    1. Brorson H. Liposuction in arm lymphedema treatment. Scandinavian Journal of Surgery 2002;92(4):287‐95. - PubMed
Bulley 2013
    1. Bulley C, Coutts F, Blyth C, Jack W, Chetty U, Barber M, et al. Prevalence and impacts of upper limb morbidity after treatment for breast cancer: a cross‐sectional study of lymphedema and function. Cancer and Oncology Research 2013;1(2):30‐9.
Campisi 2004
    1. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic‐venous microsurgery. World Journal of Surgery 2004;28(6):609‐13. - PubMed
Campisi 2010
    1. Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long‐term results. Microsurgery 2010;30(4):256‐60. - PubMed
Carl 2017
    1. Carl HH, Walia G, Bello R, Clarke‐Pearson E, Hassanein AH, Cho B, et al. Systematic review of the surgical treatment of extremity lymphedema. Journal of Reconstructive Microsurgery 2017;33(6):412‐25. - PubMed
Cormier 2012
    1. Cormier JN, Rourke L, Crosby M, Chang D, Armer J. The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004‐2010). Annals of Surgical Oncology 2012;19(2):642‐51. - PubMed
Damstra 2009
    1. Damstra RJ, Voesten HG, Klinkert P, Brorson H. Circumferential suction‐assisted lipectomy for lymphoedema after surgery for breast cancer. British Journal of Surgery 2009;96(8):859‐64. - PubMed
Doscher 2012
    1. Doscher ME, Herman S, Garfein ES. Surgical management of inoperable lymphedema: the re‐emergence of abandoned techniques. Journal of the American College of Surgeons 2012;215(2):278‐83. - PubMed
Globocan 2012
    1. Ferlay J, Soerjomataram I, Ervik M, Forman D, Bray F, Dikshit R, et al. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide. globocan.iarc.fr (accessed prior to 26 January 2019).
Hayes 2008
    1. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. Journal of Clinical Oncology 2008;26(21):3536‐42. - PubMed
Higgins 2002
    1. Higgins J, Thompson S. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58. - PubMed
Higgins 2011
    1. Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. - PMC - PubMed
Hollis 1999
    1. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319:670‐4. - PMC - PubMed
ISL 2009
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphoedema. Lymphology 2009;45:51‐60. - PubMed
Keeley 2010
    1. Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). Journal of Lymphoedema 2010;5(1):26‐37.
Launois 2002
    1. Launois R, Mègnigbêto AC, Pocquet K, Alliot F. A specific quality of life scale in upper limb lymphedema: the ULL‐27 questionnaire. Lymphology 2002;35 (Suppl)(1‐760):181‐7.
Lee 2011
    1. Lee B, Laredo J, Neville R. Current status of lymphatic reconstruction surgery for chronic lymphoedema: it is still an uphill battle!. International Journal of Angiology 2011;20:73‐80. - PMC - PubMed
Leung 2015
    1. Leung N, Furniss D, Giele H. Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema. Maturitas 2015;80(4):384‐390. - PubMed
McLaughlin 2008
    1. McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, et al. Prevalence of lymphoedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviours. Journal of Clinical Oncology 2008;26(32):5220‐6. - PMC - PubMed
Nagase 2005
    1. Nagase T, Gonda K, Inoue K, Higashino T, Fukuda N, Gorai K, et al. Treatment of lymphoedema with lymphaticovenular anastomoses. International Journal of Clinical Oncology 2005;10(5):304‐10. - PubMed
Penha 2013
    1. Penha TRL, Ijsbrandy C, Hendrix NAM, Heuts EM, Voogd AC, Meyenfeldt MF, et al. Microsurgical techniques for the treatment of breast cancer‐related lymphedema: a systematic review. Journal of Reconstructive Microsurgery 2013;29(2):99‐106. - PubMed
Petrek 1998
    1. Petrek JA, Heelan MC. Incidence of breast carcinoma‐related lymphedema. Cancer 1998;83(12 Suppl):2776‐81. - PubMed
Preston 2008
    1. Preston NJ, Seers K, Mortimer PS. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD003141.pub2] - DOI - PubMed
RevMan 2012 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rockson 2008
    1. Rockson SG. Diagnosis and management of lymphatic vascular disease. Journal of the American College of Cardiology 2008;52(10):799‐806. - PubMed
Scaglioni 2017
    1. Scaglioni MF, Arvanitakis M. Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema. Microsurgery 2017;37(8):947‐53. - PubMed
Shih 2009
    1. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphoedema after breast cancer among women of working age: a 2‐year follow‐up study. Journal of Clinical Oncology 2009;27(12):2007‐14. - PubMed
Stuiver 2012
    1. Stuiver MM, Tusscher MR, Agasi‐Idenburg CS, Lucas C, Aaronson NK, Bossuyt PMM. Conventional interventions for preventing clinically detectable upper‐limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD009765] - DOI - PMC - PubMed
Vignes 2002
    1. Vignes S, Trévidic P. Role of surgery in the treatment of lymphedema [Place de la chirurgie dans le traitement des lymphœdèmes]. La Revue de Médecine Interne 2002;23(Suppl 3):426‐30s. - PubMed
Yamamoto 2011
    1. Yamamoto T, Yamamoto N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, et al. Indocyanine green–enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plastic and Reconstructive Surgery 2011;128(4):941‐7. - PubMed
Yamamoto 2013
    1. Yamamoto T, Yamamoto N, Hara H, Mihara M, Narushima M, Koshima I. Upper extremity lymphedema index: a simple method for severity evaluation of upper extremity lymphedema. Annals of Plastic Surgery 2013;70(1):47‐9. - PubMed

MeSH terms